Report Detail

Pharma & Healthcare COVID-19 Impact on Global Non Narcotic Analgesics, Market Insights and Forecast to 2026

  • RnM4074491
  • |
  • 23 June, 2020
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Non Narcotic Analgesics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non Narcotic Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Non Narcotic Analgesics market is segmented into
Non Steroid Antiinflammatory Drug
Steroid Antiinflammatory Drug

Segment by Application, the Non Narcotic Analgesics market is segmented into
Hospital
Medical Center
Others

Regional and Country-level Analysis
The Non Narcotic Analgesics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Non Narcotic Analgesics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Non Narcotic Analgesics Market Share Analysis
Non Narcotic Analgesics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non Narcotic Analgesics business, the date to enter into the Non Narcotic Analgesics market, Non Narcotic Analgesics product introduction, recent developments, etc.
The major vendors covered:
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
Reckitt Benckiser
Endo Pharmaceuticals
...


1 Study Coverage

  • 1.1 Non Narcotic Analgesics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Non Narcotic Analgesics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Non Narcotic Analgesics Market Size Growth Rate by Type
    • 1.4.2 Non Steroid Antiinflammatory Drug
    • 1.4.3 Steroid Antiinflammatory Drug
  • 1.5 Market by Application
    • 1.5.1 Global Non Narcotic Analgesics Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Center
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Non Narcotic Analgesics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Non Narcotic Analgesics Industry
      • 1.6.1.1 Non Narcotic Analgesics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Non Narcotic Analgesics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Non Narcotic Analgesics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Non Narcotic Analgesics Market Size Estimates and Forecasts
    • 2.1.1 Global Non Narcotic Analgesics Revenue 2015-2026
    • 2.1.2 Global Non Narcotic Analgesics Sales 2015-2026
  • 2.2 Non Narcotic Analgesics Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Non Narcotic Analgesics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Non Narcotic Analgesics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Non Narcotic Analgesics Competitor Landscape by Players

  • 3.1 Non Narcotic Analgesics Sales by Manufacturers
    • 3.1.1 Non Narcotic Analgesics Sales by Manufacturers (2015-2020)
    • 3.1.2 Non Narcotic Analgesics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Non Narcotic Analgesics Revenue by Manufacturers
    • 3.2.1 Non Narcotic Analgesics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Non Narcotic Analgesics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Non Narcotic Analgesics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Non Narcotic Analgesics Revenue in 2019
    • 3.2.5 Global Non Narcotic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Non Narcotic Analgesics Price by Manufacturers
  • 3.4 Non Narcotic Analgesics Manufacturing Base Distribution, Product Types
    • 3.4.1 Non Narcotic Analgesics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Non Narcotic Analgesics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Non Narcotic Analgesics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Non Narcotic Analgesics Market Size by Type (2015-2020)
    • 4.1.1 Global Non Narcotic Analgesics Sales by Type (2015-2020)
    • 4.1.2 Global Non Narcotic Analgesics Revenue by Type (2015-2020)
    • 4.1.3 Non Narcotic Analgesics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Non Narcotic Analgesics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Non Narcotic Analgesics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Non Narcotic Analgesics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Non Narcotic Analgesics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Non Narcotic Analgesics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Non Narcotic Analgesics Market Size by Application (2015-2020)
    • 5.1.1 Global Non Narcotic Analgesics Sales by Application (2015-2020)
    • 5.1.2 Global Non Narcotic Analgesics Revenue by Application (2015-2020)
    • 5.1.3 Non Narcotic Analgesics Price by Application (2015-2020)
  • 5.2 Non Narcotic Analgesics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Non Narcotic Analgesics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Non Narcotic Analgesics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Non Narcotic Analgesics Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Non Narcotic Analgesics by Country
    • 6.1.1 North America Non Narcotic Analgesics Sales by Country
    • 6.1.2 North America Non Narcotic Analgesics Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Non Narcotic Analgesics Market Facts & Figures by Type
  • 6.3 North America Non Narcotic Analgesics Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Non Narcotic Analgesics by Country
    • 7.1.1 Europe Non Narcotic Analgesics Sales by Country
    • 7.1.2 Europe Non Narcotic Analgesics Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Non Narcotic Analgesics Market Facts & Figures by Type
  • 7.3 Europe Non Narcotic Analgesics Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Non Narcotic Analgesics by Region
    • 8.1.1 Asia Pacific Non Narcotic Analgesics Sales by Region
    • 8.1.2 Asia Pacific Non Narcotic Analgesics Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Non Narcotic Analgesics Market Facts & Figures by Type
  • 8.3 Asia Pacific Non Narcotic Analgesics Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Non Narcotic Analgesics by Country
    • 9.1.1 Latin America Non Narcotic Analgesics Sales by Country
    • 9.1.2 Latin America Non Narcotic Analgesics Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Non Narcotic Analgesics Market Facts & Figures by Type
  • 9.3 Central & South America Non Narcotic Analgesics Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Non Narcotic Analgesics by Country
    • 10.1.1 Middle East and Africa Non Narcotic Analgesics Sales by Country
    • 10.1.2 Middle East and Africa Non Narcotic Analgesics Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Non Narcotic Analgesics Market Facts & Figures by Type
  • 10.3 Middle East and Africa Non Narcotic Analgesics Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi S.A.
    • 11.1.1 Sanofi S.A. Corporation Information
    • 11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi S.A. Non Narcotic Analgesics Products Offered
    • 11.1.5 Sanofi S.A. Recent Development
  • 11.2 Novartis AG
    • 11.2.1 Novartis AG Corporation Information
    • 11.2.2 Novartis AG Description, Business Overview and Total Revenue
    • 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis AG Non Narcotic Analgesics Products Offered
    • 11.2.5 Novartis AG Recent Development
  • 11.3 GlaxoSmithKline PLC
    • 11.3.1 GlaxoSmithKline PLC Corporation Information
    • 11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
    • 11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GlaxoSmithKline PLC Non Narcotic Analgesics Products Offered
    • 11.3.5 GlaxoSmithKline PLC Recent Development
  • 11.4 Pfizer
    • 11.4.1 Pfizer Corporation Information
    • 11.4.2 Pfizer Description, Business Overview and Total Revenue
    • 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer Non Narcotic Analgesics Products Offered
    • 11.4.5 Pfizer Recent Development
  • 11.5 Reckitt Benckiser
    • 11.5.1 Reckitt Benckiser Corporation Information
    • 11.5.2 Reckitt Benckiser Description, Business Overview and Total Revenue
    • 11.5.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Reckitt Benckiser Non Narcotic Analgesics Products Offered
    • 11.5.5 Reckitt Benckiser Recent Development
  • 11.6 Endo Pharmaceuticals
    • 11.6.1 Endo Pharmaceuticals Corporation Information
    • 11.6.2 Endo Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.6.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Endo Pharmaceuticals Non Narcotic Analgesics Products Offered
    • 11.6.5 Endo Pharmaceuticals Recent Development
  • 11.1 Sanofi S.A.
    • 11.1.1 Sanofi S.A. Corporation Information
    • 11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi S.A. Non Narcotic Analgesics Products Offered
    • 11.1.5 Sanofi S.A. Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Non Narcotic Analgesics Market Estimates and Projections by Region
    • 12.1.1 Global Non Narcotic Analgesics Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Non Narcotic Analgesics Revenue Forecast by Regions 2021-2026
  • 12.2 North America Non Narcotic Analgesics Market Size Forecast (2021-2026)
    • 12.2.1 North America: Non Narcotic Analgesics Sales Forecast (2021-2026)
    • 12.2.2 North America: Non Narcotic Analgesics Revenue Forecast (2021-2026)
    • 12.2.3 North America: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Non Narcotic Analgesics Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Non Narcotic Analgesics Sales Forecast (2021-2026)
    • 12.3.2 Europe: Non Narcotic Analgesics Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Non Narcotic Analgesics Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Non Narcotic Analgesics Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Non Narcotic Analgesics Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Non Narcotic Analgesics Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Non Narcotic Analgesics Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Non Narcotic Analgesics Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Non Narcotic Analgesics Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Non Narcotic Analgesics Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Non Narcotic Analgesics Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Non Narcotic Analgesics Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Non Narcotic Analgesics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Non Narcotic Analgesics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Non Narcotic Analgesics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Non Narcotic Analgesics. Industry analysis & Market Report on COVID-19 Impact on Global Non Narcotic Analgesics is a syndicated market report, published as COVID-19 Impact on Global Non Narcotic Analgesics, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Non Narcotic Analgesics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,084.90
    4,627.35
    6,169.80
    3,595.80
    5,393.70
    7,191.60
    605,670.00
    908,505.00
    1,211,340.00
    325,650.00
    488,475.00
    651,300.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report